• NEBANNER

Sama da dala biliyan 9 maganin tauraruwar Qilu shine samfurin gida na farko da aka bayar da rahoton samarwa.

 

1.Sama da dala biliyan 9 maganin tauraruwar Qilu shine samfurin gida na farko da aka bayar da rahoton samarwa.Magungunan Qilu sun sami karɓuwar CDE don aikace-aikacen jeri na maganin alluran intraocular na Aflibercept wanda sabon nau'in magani na 3.3 ya gabatar, wanda shine farkon da aka ba da rahoton samar da irin wannan magani na nazarin halittu na Aflibercept a China.

 

2.A ranar 11 ga Mayu, aikace-aikacen jeri na levosalbuterol hydrochloride atomized inhalation bayani wanda Hunan Warner Pharmaceutical Co., Ltd. ya ƙaddamar tare da nau'in magani na 3 na CDE.Ana amfani da Levosalbuterol β 2 agonists mai karɓa.Bisa kididdigar da aka yi a intanet, an ce, sayar da maganin shakar numfashi ta tashar L-salbutamol Hydrochloride Aerosol a cibiyoyin kiwon lafiya na jama'a a kasar Sin a shekarar 2021 ya kai kusan yuan miliyan 200, inda aka samu karuwar sama da kashi 3209 cikin dari a duk shekara.

 

3.Enoxaparin sodium allura ya haifar a cikin kamfani na biyar da aka kimanta.Gabatowar sayayya ta tsakiya ya sanya 'yan wasa a fagen heparin rashin hutu.Bisa kididdigar da aka yi ta intanet, an ce, cinikin heparin na tashar jiragen ruwa da karancin kwayoyin da ake sayar da shi a cibiyoyin kiwon lafiyar jama'ar kasar Sin ya zarce Yuan biliyan 12 a shekarar 2021, wanda ya karu da kashi 12.98 cikin dari a duk shekara.Daga cikin manyan samfuran 10, allurar sodium na enoxaparin ta ci gaba da jagoranci, kuma tallace-tallace na samfuran 9 ya karu sosai.Daga cikin kamfanonin haɗin gwiwar shirye-shiryen Heparin API guda biyar, Heprui, Jianyou hannun jari da Changshan Pharmaceutical Pharmaceutical sun jagoranci kudaden shiga na kasuwanci na Heparin a cikin 2021, suna samar da yanayi mai ban sha'awa.

 

4.An gudanar da bikin kaddamar da tashar shigo da magunguna ta Zhongshan da kashin farko na hana shigo da muggan kwayoyi a tashar jiragen ruwa ta Sinotrans Wharf ta Zhongshan dake yankin raya Torch na Zhongshan na lardin Guangdong.Kashi na farko na "cefotaxime sodium" da "Zhupo foda ga yara" da Guangdong Jincheng Jinsu Pharmaceutical Co., Ltd. da Hong Kong Baohetang Pharmaceutical Co., Ltd suka shigo da su cikin nasarar kammala aikin kwastam, ya zama rukuni na farko na magungunan da aka shigo da su. share a tashar jiragen ruwa.

 

5.A ranar 25 ga Mayu, aosaikang ya sake ƙaddamar da aikace-aikacen tallace-tallace na aji 2.2 sababbin magunguna na dextrolanzoprazole don allura.Takeda Pharmaceutical kawai yana da shirye-shiryen baki na dextrolanzolanzole.A cikin 2021, ta sayar da fiye da yen biliyan 50.7 (kimanin dalar Amurka miliyan 400) a duniya.A halin yanzu, babu shigo ko amincewa cikin gida na samfuran da ke da alaƙa da wannan nau'in a cikin kasuwar cikin gida.

 

6.A ranar 25 ga Mayu, Zhejiang Puli Pharmaceutical Co., Ltd.Memantine shine mafi kyawun siyar da nau'ikan magungunan cutar hauka don magungunan tsarin juyayi.A halin yanzu, akwai capsules, allunan da wakilan ruwa na baka a kasuwa, kuma ba a yarda da granules don jeri ko shigo da su ba.Puli shine kamfani na farko da ya nemi aikace-aikacen asibiti don granules.

 

7.A ranar 27 ga Mayu, Shandong sabon zamanin Pharmaceutical Co., Ltd. ya ƙaddamar da aikace-aikacen jeri don nau'ikan kwaikwayi nau'ikan nau'ikan allunan etoxaban toluenesulfonate guda huɗu.A halin yanzu, babu wani magani na cikin gida na wannan samfurin a kasuwa.Hainan Xiansheng Pharmaceutical Co., Ltd., Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd. da Nanjing Hailing Pharmaceutical Co., Ltd. na Yangzijiang Pharmaceutical Group sun gabatar da su don samar da, wanda ake dubawa da amincewa, da kuma jayayya a kan na farko generic. miyagun ƙwayoyi yana ƙara tsananta.Edoxaban wani zaɓin factor factor Xa inhibitor ne wanda Sankyo na farko ya haɓaka.An fara amincewa da shi don maganin thromboembolism a Japan a cikin 2011, sa'an nan kuma an amince da wasu sababbin alamu.A cikin 2021, tallace-tallacen duniya ya kai yen biliyan 189.4 (kimanin dalar Amurka biliyan 1.5).

 

JinDun Medicalyana da haɗin gwiwar bincike na kimiyya na dogon lokaci tare da fasahar kere-kere tare da jami'o'in kasar Sin.Tare da wadataccen albarkatun kiwon lafiya na Jiangsu, tana da dangantakar kasuwanci ta dogon lokaci tare da Indiya, kudu maso gabashin Asiya, Koriya ta Kudu, Japan da sauran kasuwanni.Hakanan yana ba da sabis na kasuwa da tallace-tallace a cikin gabaɗayan tsari daga matsakaici zuwa ƙãre samfurin API.Yi amfani da tarin albarkatun JinDun Chemical a cikin sinadarai na fluorine don samarwasabis na gyare-gyaren sinadarai na musammanga abokan tarayya.Samar da sabbin abubuwa da ayyukan bincike na ƙazanta don ƙaddamar da abokan ciniki.

图片.webp (1)


Lokacin aikawa: Nuwamba-07-2022